Delivery Order SPE2DB20D2001-SPE2DB23FM30G
Award Date 11/22/22
Potential Completion Date 11/23/22
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE7GS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,729.93 firm fixed-price delivery order is for the supply of VALCYTE 450 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Valcyte 450 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $4,242.15 and a completion date of June 5, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract provides for the delivery of VALCYTE 450 MG TABLET 60S, a pharmaceutical product, to support military treatment facilities and other federal medical institutions. The award has a ceiling value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,907.97, is for the delivery of Valganciclovir 450 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,034.57, is a delivery order contract to provide Valacyclovir HCL 1 gram tablets. The contract has an ultimate completion date of January 13, 2025 and is a firm-fixed price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,605.14, is for the delivery of 60 count valganciclovir 450 mg tablets. It is a firm-fixed price delivery order with a completion date of December 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,727,588 units of Valganciclovir 450 mg tablets. The $21,045.78 firm-fixed-price delivery order has a completion date of December 17, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.76 firm fixed-price delivery order is for 4,566,672,142 tablets of the antiviral medication Valacyclovir HCl 500 mg. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
- This federal contract award is for the delivery of Valacyclovir HCL 500 mg tablets to the Defense Logistics Agency (DLA). The $3,110.84 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Valacyclovir HCL 1 gram tablets. The $1,363.09 fixed-price delivery order has a performance period through May 6, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00. This IDC enables...